Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Acute Kidney Failure

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Acute Kidney Failure in 2 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jonassen, TE1
Graebe, M1
Promeneur, D1
Nielsen, S1
Christensen, S1
Olsen, NV1
Begany, DP1
Carcillo, JA1
Herzer, WA1
Mi, Z1
Jackson, EK1

Other Studies

2 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Acute Kidney Failure

ArticleYear
Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Acute Kidney In

2002
Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:1

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Acute Kidney Injury; Animals; Blood Flow Velocity; E

1996